Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intradermal acupuncture for major depressive disorder
NCT05605002Recruiting
- Start
- Jan 2022
- Primary completion
- Dec 2025
- Countries
- 1
01
Overview
Randomised, single-blind trial in major depressive disorder (MDD) (3 arms). Primary endpoint: Hamilton Depression Scale-17 at 10 weeks. Started Jan 2022; status: recruiting.
02
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT05605002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05605002.